Top Markets
Coin of the day
Circio Holding ASA Circio Holding ASA

Circio Holding ASA

CRNA
Pozycja w akcjach #18604
Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in... Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in 2010, specializes in the development of advanced circular RNA and immunotherapy treatments. Among its key innovations is TG01, a cancer vaccine aimed at specific driver mutations, which is currently progressing through three clinical trials for indications including multiple myeloma, pancreatic cancer, and lung cancer. The company also pioneers the circVec circRNA vector platform, an adaptable genetic module designed to facilitate the creation of diverse functional circular RNAs within human cells. This circVec platform is further supported by a collaborative agreement with Certest Biotec, S.L., focusing on its formulation. Formerly known as Targovax ASA, the company officially rebranded to Circio Holding ASA in May 2023.
Cena akcji
$0.88044964
Ostatnia synchronizacja: 2026-07-31
Kapitalizacja rynkowa
$192.54M
Zmiana (1 dzień)
-0.71%
Zmiana (1 rok)
1,362.12%
Kraj
NO
Handel Circio Holding ASA (CRNA)

Kategoria

EPS dla Circio Holding ASA (CRNA)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy Circio Holding ASA, obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla Circio Holding ASA od 2026 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
Za mało danych dla podanych dat.
EPS dla podobnych firm lub konkurentów
Firma EPS Różnica w EPS Kraj
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH